NEW YORK (GenomeWeb News) – Pacific Biosciences has appointed David Baltimore to its board. Since 2006, Baltimore has been president emeritus and the Robert Andrews Millikan Professor of Biology at the California Institute of Technology, and he was president of Caltech from 1997 to 2006. Before that, he was a professor at the Massachusetts Institute of Technology and Rockefeller University, where he also served as president. He was co-recipient of the Nobel Prize in medicine in 1975, and received the National Medal of Science in 1999.
Signature Diagnostics has named Rainer Kramer to be chief business officer. Kramer formerly was VP of corporate business development at Jerini, and before that he worked in research and business development at MorphoSys AG and at Amgen.
IO Informatics has appointed Bruce McManus, Elgar Pichler, and Nigam Shah to serve on its scientific advisory board.
McManus is a professor at the University of British Columbia Department of Pathology and Laboratory Medicine and director of the James Hogg Research Centre. Pichler is a computational biology consultant, and he is a member of the World Wide Web Consortium's Semantic Web Health Care and Life Sciences Interest Group, and he formerly was a senior manager and bioinformaticist at AstraZeneca. Shah is an assistant professor of medicine and medical bioinformatics at Stanford University.
OncoMethylome Sciences has appointed Melissa Thompson to be VP of regulatory affairs and quality assurance and Christopher Thibodeau to be VP of commercial operations.
Thompson has worked as a consultant for companies such as Affymetrix, Inverness, Allegro Diagnostics, ExonHit Therapeutics, Signature Genomic Laboratories, and others. Thibodeau was senior director of marketing at Agendia, VP of sales and marketing for Numira Biosciences, national director of sales at US Labs, and he worked in sales and marketing at Ventana Medical.
The John D. and Catherine T. MacArthur Foundation has given one of its $500,000 "genius" fellowship awards to Carlos Bustamante, who is a professor of genetics and population biology at Stanford University. Bustamente won the award for his research into the genome focused on understanding genetic diversity, population migration, and the mechanisms of evolution.
Predictive Biosciences has added Thomas Ross and Randal Vader to its executive ranks, appointing them to chief commercial officer and VP of clinical and regulatory affairs, respectively.
Ross formerly was VP of North American MDx sales at Qiagen, and before that at Digene he was responsible for expanding physician and lab sales. Vader formerly worked to obtain US Food and Drug Administration clearance for a molecular test for the herpes simplex virus for EraGen Biosiences.
Integromics this week said that it has named Michael McManus to be company president and CEO. He will lead the firm's expansion around the world, with a focus on proteomics and activities in the US and Asia.
McManus led GenomeQuest's corporate marketing, strategic alliances, product marketing, and development efforts. He also was VP of business development for the BioSciences Group at Fujitsu Computer Systems, an executive VP and COO at Anvil Informatics, and VP of marketing and business development at CambridgeSoft.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.